Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Proteostasis Ther (PTI)

Proteostasis Ther (PTI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 78,739
  • Shares Outstanding, K 51,129
  • Annual Sales, $ 2,840 K
  • Annual Income, $ -61,830 K
  • 60-Month Beta 0.38
  • Price/Sales 15.75
  • Price/Cash Flow N/A
  • Price/Book 1.32

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.28
  • Number of Estimates 2
  • High Estimate -0.26
  • Low Estimate -0.31
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.40 +11.43%
on 02/28/20
2.20 -29.09%
on 02/21/20
-0.20 (-11.36%)
since 01/28/20
3-Month
1.20 +30.00%
on 12/19/19
4.72 -66.95%
on 12/11/19
-0.84 (-35.00%)
since 11/27/19
52-Week
0.61 +155.74%
on 08/14/19
4.72 -66.95%
on 12/11/19
-2.56 (-62.14%)
since 02/28/19

Most Recent Stories

More News
Proteostasis (PTI) to Report Q4 Earnings: What's in Store?

We expect Proteostasis Therapeutics (PTI) to provide updates on its pipeline when its releases fourth-quarter 2019 results.

AMAG : 7.75 (+2.79%)
SAGE : 47.00 (-9.63%)
ADRO : 3.05 (+2.69%)
PTI : 1.56 (+1.30%)
Proteostasis Therapeutics Announces New Publication on the Mechanism of Action of a Novel Class of CFTR Modulators Called Amplifiers in the Journal of Cystic Fibrosis

Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced...

PTI : 1.56 (+1.30%)
Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis

Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and CF Europe,...

PTI : 1.56 (+1.30%)
The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis

The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis

ABEO : 3.08 (-6.95%)
ONTX : 0.43 (-8.55%)
PTI : 1.56 (+1.30%)
EBF : 20.10 (-3.27%)
APLT : 41.55 (-0.24%)
US Dollar Flexes Muscles Against Other Currencies: 5 Winners

The US dollar drew support from a healthy domestic economy, and Fed's cautiously optimistic stance about holding interest rates despite the coronavirus outbreak.

ABEO : 3.08 (-6.95%)
ONTX : 0.43 (-8.55%)
PTI : 1.56 (+1.30%)
EBF : 20.10 (-3.27%)
APLT : 41.55 (-0.24%)
The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics

The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics

AAPL : 273.36 (-0.06%)
EBMT : 19.39 (-0.31%)
ABEO : 3.08 (-6.95%)
ONTX : 0.43 (-8.55%)
PTI : 1.56 (+1.30%)
Coronavirus to Hit Apple Sales: Invest in Domestic Producers

With the coronavirus threat increasing, it's quite evident that companies having significant exposure to China and the global economy are vulnerable. However, domestic producers of goods should remain...

AAPL : 273.36 (-0.06%)
TSLA : 667.99 (-1.62%)
EBMT : 19.39 (-0.31%)
ABEO : 3.08 (-6.95%)
ONTX : 0.43 (-8.55%)
PTI : 1.56 (+1.30%)
Proteostasis Therapeutics Announces Keystone Symposia Presentation of Organoid Study from More than 300 Adult CF Patients

Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases...

PTI : 1.56 (+1.30%)
Proteostasis Therapeutics Regulatory Update Following Scientific Advice Meeting with MHRA

Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced...

PTI : 1.56 (+1.30%)
Is Proteostasis Therapeutics (PTI) Stock Outpacing Its Medical Peers This Year?

Is (PTI) Outperforming Other Medical Stocks This Year?

PTI : 1.56 (+1.30%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade PTI with:

Business Summary

Proteostasis Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics to treat diseases caused by an imbalance in the proteostasis network primarily in the United States. Proteostasis Therapeutics, Inc. is based in Cambridge, Massachusetts....

See More

Key Turning Points

2nd Resistance Point 1.71
1st Resistance Point 1.63
Last Price 1.56
1st Support Level 1.44
2nd Support Level 1.33

See More

52-Week High 4.72
Fibonacci 61.8% 3.15
Fibonacci 50% 2.66
Fibonacci 38.2% 2.18
Last Price 1.56
52-Week Low 0.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar